Ultragenyx Pharmaceutical
RARE
#4574
Rank
S$2.82 B
Marketcap
S$29.26
Share price
-3.40%
Change (1 day)
-47.74%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: S$2.82 Billion

As of January 2026 Ultragenyx Pharmaceutical has a market cap of S$2.82 Billion. This makes Ultragenyx Pharmaceutical the world's 4574th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026S$2.82 B-33.34%
2025S$4.23 B-22.29%
2024S$5.45 B5.09%
2023S$5.18 B19.1%
2022S$4.35 B-43.81%
2021S$7.74 B-36.04%
2020S$12.11 B263.79%
2019S$3.33 B10.24%
2018S$3.02 B14.35%
2017S$2.64 B-36.46%
2016S$4.15 B-32.61%
2015S$6.16 B233.22%
2014S$1.85 B

End of Day market cap according to different sources

On Jan 15th, 2026 the market cap of Ultragenyx Pharmaceutical was reported to be:

S$2.92 Billion
by Nasdaq info icon info icon
S$2.92 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioMarin Pharmaceutical
BMRN
S$13.60 B 382.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$5.71 B 102.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$0.93 B-66.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
S$0.65 B-76.94%๐Ÿ‡บ๐Ÿ‡ธ USA